What type of study is this?

This is a In Vitro Study study (also classified as: Animal Study).

August 22, 2025ASAIO Journal

In Vitro Hemocompatibility of the BiVACOR Total Artificial Heart Near the Boundaries of Clinical Operation

View Full Paper

Ask AI

Bookmark

The BiVACOR total artificial heart showed promising hemocompatibility near clinical operation limits, with varied flow conditions.
At low flow, the normalized index of hemolysis was higher for the BiVACOR TAH (0.003 g/100 L) versus a clinical comparator (0.001 g/100 L).
In high flow conditions, the hemolysis rates were similar, with the TAH at 0.004 g/100 L and the comparator at 0.002 g/100 L.
These findings imply that the TAH can maintain hemocompatibility under conditions where traditional devices may struggle.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

In vitro tests show hemocompatibility of the BiVACOR total artificial heart compared to clinical devices, suggesting its viability for varied flow conditions.

Cite This Study

McNamee et al. (2025) studied this question.

synapsesocial.com/papers/68af5f0dad7bf08b1eae1978 https://doi.org/10.1097/mat.0000000000002536

View Full Paper

Ask AI

Bookmark

Implication

In vitro tests show hemocompatibility of the BiVACOR total artificial heart compared to clinical devices, suggesting its viability for varied flow conditions.

In Vitro Hemocompatibility of the BiVACOR Total Artificial Heart Near the Boundaries of Clinical Operation

Key Points

Discussion

Implication

Cite This Study

In Vitro Hemocompatibility of the BiVACOR Total Artificial Heart Near the Boundaries of Clinical Operation

Key Points

Discussion

Implication

Cite This Study